The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis

Volume: 38, Issue: 7, Pages: 1480 - 1486
Published: Jul 1, 2011
Abstract
There has been a marked increase in the past 15 years in the number and quality of clinical trials in the idiopathic inflammatory vasculitides, especially the small-vessel vasculitides known as antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis [AAV; granulomatosis, with polyangiitis (Wegener's)]. These trials have been conducted by multicenter, international groups in Europe and the United States with financial support...
Paper Details
Title
The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis
Published Date
Jul 1, 2011
Volume
38
Issue
7
Pages
1480 - 1486
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.